Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach

American Journal of Clinical Pathology

Volumn 140, Issue 5, 2013, Pages 643-650

  Seegmiller, Adam C ^a   Kim, Annette S ^a   Mosse, Claudio A ^a,b   Levy, Mia A ^c   Thompson, Mary Ann ^a   Kressin, Megan K ^a,b   Jagasia, Madan H ^c   Strickland, Stephen A ^c   Reddy, Nishitha M ^c   Marx, Edward R ^a   Sinkfield, Kristy J ^a   Pollard, Herschel N ^a   Plummer, W Dale ^a   Dupont, William D ^a   Shultz, Edward K ^a,c   Dittus, Robert S ^b,c   Stead, William W ^a,c   Santoro, Samuel A ^a   Zutter, Mary M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetics; Hematopathology; Informatics; Molecular diagnostics

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; FALSE POSITIVE RESULT; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEALTH CARE COST; HEALTH CARE QUALITY; HEMATOLOGIC MALIGNANCY; KARYOTYPE; PATIENT CARE; PERSONALIZED MEDICINE; PRIORITY JOURNAL;

GENETICS; HEMATOPATHOLOGY; INFORMATICS; MOLECULAR DIAGNOSTICS;

BONE MARROW; BONE MARROW CELLS; CLINICAL PROTOCOLS; EVIDENCE-BASED MEDICINE; HEMATOLOGIC NEOPLASMS; HUMANS; INDIVIDUALIZED MEDICINE; PATIENT CARE TEAM; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84886289785     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP8CKE9NEINQFL     Document Type: Article

References (32)

1. McGinley PJ, Kilpatrick ES. Tumour markers: their use and misuse by clinicians. Ann Clin Biochem. 2003;40(pt 6):643-647.
2. Walker PL, Crook M. Tumour marker requesting in primary care and the role of the laboratory. J Clin Pathol. 2011;64:443-446.
3. Rao GG, Crook M, Tillyer ML. Pathology tests: is the time for demand management ripe at last? J Clin Pathol. 2003;56:243-248.
4. van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA. 1998;280:550-558.
5. Fryer AA, Hanna FW. Managing demand for pathology tests: financial imperative or duty of care? Ann Clin Biochem. 2009;46(pt 6):435-437.
6. Qaseem A, Alguire P, Dallas P, et al. Appropriate use of screening and diagnostic tests to foster high-value, costconscious care. Ann Intern Med. 2012;156:147-149.
7. Brody H. From an ethics of rationing to an ethics of waste avoidance. N Engl J Med. 2012;366:1949-1951.
8. Kawamoto K, Houlihan CA, Balas EA, et al. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765.
9. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223-1238.
10. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med. 2012;157:29-43.
11. van Wijk MA, van der Lei J, Mosseveld M, et al. Assessment of decision support for blood test ordering in primary care: a randomized trial. Ann Intern Med. 2001;134:274-281.
12. Wang TJ, Mort EA, Nordberg P, et al. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Arch Intern Med. 2002;162:1885-1890.
13. May TA, Clancy M, Critchfield J, et al. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol. 2006;126:200-206.
14. Poley MJ, Edelenbos KI, Mosseveld M, et al. Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care: evidence from a controlled prospective study in the Netherlands. Clin Chem. 2007;53:213-219.
15. Hutton HD, Drummond HS, Fryer AA. The rise and fall of C-reactive protein: managing demand within clinical biochemistry. Ann Clin Biochem. 2009;46(pt 2):155-158.
16. Georgiou A, Lam M, Allardice J, et al. Troponin testing in the emergency department: a longitudinal study to assess the impact and sustainability of decision support strategies. J Clin Pathol. 2012;65:546-550.
17. Neilson EG, Johnson KB, Rosenbloom ST, et al. The impact of peer management on test-ordering behavior. Ann Intern Med. 2004;141:196-204.
18. Harris NL, Campo E, Jaffe ES, et al. Introduction to the WHO classification of tumours of haematopoietic and lymphoid tissue. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC; 2008:14-15.
19. Swords RT, Dezube BJ, Medeiros BC. Personalized medicine for acute myelogenous leukemia-at the entrance gate. Am J Hematol. 2011;86:631-632.
20. Russell SJ, Rajkumar SV. Multiple myeloma and the road to personalised medicine. Lancet Oncol. 2011;12:617-619.
21. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
22. Howlader N, Noone AM, Krapcho M, et al. Previous version: SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer Institute; 2012. Available at http://seer.cancer.gov/csr/1975-2009- pops09/index.html.
23. Dupont WD. Statistical Modeling for Biomedical Researchers: A Simple Introduction to the Analysis of Complex Data. 2nd ed. Cambridge, UK: Cambridge University Press; 2009.
24. Hamilton JD. Time Series Analysis. Princeton, NJ: Princeton University Press; 1994.
25. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
26. Agresti A. Categorical Data Analysis. 2nd ed. Hoboken, NJ: John Wiley; 2002.
27. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC; 1994.
28. Brunning RD, Orazi A, Germing U, et al. Myelodysplastic syndromes/neoplasms, overview. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC; 2008:88-93.
29. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307:1513-1516.
30. Personalized Medicine: Trends and Prospects for the New Science of Genetic Testing and Molecular Diagnostics. Minnetonka, MN: UnitedHealth Center for Health Reform & Modernization; 2012.
31. Etheredge LM. A rapid-learning health system. Health Aff (Millwood). 2007;26:w107-w118.
32. Abernethy AP, Etheredge LM, Ganz PA, et al. Rapid-learning system for cancer care. J Clin Oncol. 2010;28:4268-4274.